Abstract Management of anterior skull base tumors is complex due to the anatomic detail of the region and the variety of tumors that occur in this area. Currently, the "gold standard" for surgery is the anterior craniofacial approach. Craniofacial resection represents a major advance in the surgical treatment of tumors of the paranasal sinuses involving anterior skull base. It allows wide exposure of the complex anatomical structures at the base of skull permitting monobloc tumor resection. This study presents a series of 18 patients with anterior skull base tumors, treated by a team of head-neck surgeons and neurosurgeons. The series included 15 malignant tumors of the nose and paranasal sinuses and 3 extensive benign lesions. All tumors were resected by a combined bi-frontal craniotomy and rhinotomy. The skull base was closed with a pediculated pericranial flap and a split-thickness free skin graft underneath. There were no postoperative problems of wound infection, cerebrospinal fluid-leakage or meningitis. Recurrent tumor growth or systemic metastasis occurred in 3 out of 15 patients with malignant tumors, 6 months to 2 years postoperatively. Craniofacial resection was thus found to give excellent results with low morbidity in malignant lesions and can also be adapted for benign tumors of anterior skull base.
Background
In 1954, Smith reported the first anterior craniofacial resection in a patient presenting with a tumor arising in the frontal sinus. Ketcham et al. reported the first series of patients treated with an anterior craniofacial resection for tumors arising in the ethmoid sinuses. This report included the indications, morbidity, and outcome of the procedure and included a systematic description of the surgical technique. The oncologic principles of anterior craniofacial resection remain as described by Ketcham and involve an enbloc resection of tumor, including the ethmoid sinuses, superior nasal septum, and floor of the anterior cranial fossa, corresponding to the interorbital area (i.e. anterior craniofacial resection) or extended laterally to include part of the bony orbit or its soft tissue contents (anterolateral craniofacial resection). Subsequent reports included larger series of patients and multiple modifications of Ketcham's original surgical technique. These latter reports incorporate technical advances brought to craniofacial surgery by Tessier, such as the use of the subfrontal technique adopted for oncologic surgery by Derome. These modifications improved the visualization of the tumor, facilitating its total removal, and decreased, although did not eliminate, the morbidity due to brain retraction. Recently, endoscopic and endoscopic-assisted techniques have been developed to extirpate selected tumors that traditionally have been resected using a subfrontal approach.
Introduction
Malignant tumors of the sinonasal tract comprise approximately 3% of the malignancies that arise in the upper aerodigestive tract. Approximately 10% of tumors that arise in the sinonasal tract originate in the ethmoid and/or frontal sinuses and are likely to involve the anterior cranial base. The craniofacial approach has gradually evolved over the past five decades into a safe and reliable technique for resecting both benign and malignant tumors involving the anterior cranial base. It can be extended and incorporated as a part of a more complex resection involving the infratemporal fossa and anterolateral cranial base, as well as the middle cranial fossa, cavernous sinus, etc. The tumors most commonly requiring combined anterior craniofacial surgery usually begin in the nose or sinuses. Tumors with a primary intracranial origin such as meningioma, chordoma or chondrosarcoma require combined resection when they clearly violate the anterior fossa floor.
Cancers of the paranasal sinuses or nasal cavity are the most common malignant tumors of the anterior skull base. A wide variety of tumors occur in this location, such as cancers of endodermal, mesodermal and epidermal origins, including squamous cell carcinoma, melanoma, lymphoma, sarcoma, hemangiopericytoma, malignant giant cell tumor, basal cell carcinoma, plasmacytoma, adenoid cystic carcinoma, mucoepidermoid carcinoma, malignant meningioma and metastatic malignancies.
Surgical technique
The anterior craniofacial approach incorporates a combination of transfacial and transcranial procedures. The facial approach consists of a graduated greater exposure depending on the extent of disease. The basic is done through a lateral rhinotomy approach coupled with a low craniotomy. The lateral rhinotomy incision may be extended into a Weber-Ferguson incision if a more extensive maxillary excision is required. If preoperative imaging studies confirm the presence of tumor in orbit, the soft tissues of the orbit, then orbital exenteration may be facilitated by extending the incision laterally to include a portion of the eyelids.
The craniotomy is tailored according to the extent of involvement of the anterior fossa floor, the subcranial tumor location, and the degree of dural or frontal lobe invasion. A bi-coronal scalp incision is made running 2-3 cm behind the hairline. The flap is elevated in the subgaleal plane down to the eyebrows, then to the lateral orbital walls laterally and just below the nasal glabella medially. A large flap of pericranial tissue is created that will be used for later reconstruction. As the dissection proceeds the brows, the supratrochlear and supraorbital neurovascular bundles are exposed and preserved. The anterior cranial fossa is then exposed by removing a segment of bone which may be pedicled on the temporalis muscle or completely separated. The lower horizontal bone cut should be kept low to lessen the need for subsequent brain retraction. Withdrawing 25-50 ml of cerebrospinal fluid from the lumbar subarachnoid catheter, lowering Pco 2 through controlled hyperventilation, and occasionally administering mannitol or steroids further reduce the need for mechanical frontal lobe retraction.
The dura is then carefully dissected off the cristagalli and cribriform plate dividing the dural sleeves that extend along the olfactory nerves. The intracranial portion of the tumor extension is then assessed. If it involves the dura or in certain situations, frontal lobe this will have to be resected, together with the tumor, if the dura is intact, it is retracted back to the planum sphenoidale.
Once the head and neck surgeon has completed the exposure and mobilization of the tumor transfacially a chisel or drill is used either from above or below to make the necessary bone cuts to encompass the tumor and deliver the specimen (Fig. 1 and 4) .
Reconstruction
The pericranium is used for anterior cranial fossa reconstruction. Unless a large amount of anterior cranial fossa bone has been resected and concern for brain herination exists, it is usually not necessary to place a bone graft across the bony defect.
In all cases, an exclusive nasal pack is placed for at least 5 days postoperatively and a lumbar drain kept for the same duration. In significantly larger defects, particularly if orbital exenteration and facial skin is excised, a bulky free flap is considered.
Imaging studies
Imaging using CT scan and/or MRI is recommended to delineate the extent of the tumor, especially in areas that are not amenable to endoscopic examination, such as the cranial cavity, orbit, other paranasal sinuses, and soft tissues of the face, pterygopalatine, and infratemporal fossa. CT scanning is superior to MRI in defining the bony boundaries. Use of contrast during CT scanning can help estimate the vascularity of the tumor and demonstrates its relationship to the great vessels and other neurovascular structures such as dura, brain and cranial nerves. MRI usually is reserved for patients presenting with invasion of soft tissues, most importantly orbit and brain. Positron 
